Rethinking bronchiectasis as an inflammatory disease

Keyphrases

• Inflammatory Diseases 100%
• Bronchiectasis 100%
• Anti-inflammatory Therapy 40%
• Clinical Trials 20%
• Risk Reduction 20%
• Clinical Practice 20%
• Complex Interactions 20%
• Asthma 20%
• Inflammation 20%
• Constriction 20%
• Remission 20%
• Chronic Inflammatory Diseases 20%
• Disease Activity 20%
• Patient Care 20%
• Anti-inflammatory Agents 20%
• Airway Inflammation 20%
• Early Identification 20%
• Therapeutic Approaches 20%
• Infection Management 20%
• Smooth muscle 20%
• Current Therapeutics 20%
• Repurposing 20%
• At-risk Individuals 20%
• Lung Damage 20%
• Disease Concept 20%
• Long-term Antibiotics 20%
• Treatment Paradigms 20%
• Mucociliary Clearance 20%
• Mucus Clearance 20%

Medicine and Dentistry

• Inflammatory Disorder 100%
• Bronchiectasis 100%
• Infection 40%
• Anti-Inflammatory Drug 40%
• Clinical Trial 20%
• Mucus 20%
• Asthma 20%
• Patient Care 20%
• Ligation 20%
• Respiratory Tract Inflammation 20%
• Disease Activity 20%
• Antiinflammatory Agent 20%
• Infectious Disease 20%
• Smooth Muscle 20%
• Mucociliary Clearance 20%
• Antibiotics 20%
• Diseases 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammatory Disease 100%
• Bronchiectasis 100%
• Infection 40%
• Anti-Inflammatory Drug 40%
• Diseases 40%
• Clinical Trial 20%
• Antibiotics 20%
• Asthma 20%
• Remission 20%
• Inflammation 20%
• Antiinflammatory Agent 20%
• Respiratory Tract Inflammation 20%
• Disease Activity 20%
• Repurposing 20%